Unit Pulmonary Hypertension: Pathophysiology and Novel Therapies
Hypertension Artérielle Pulmonaire: Physiopathologie et Innovation Thérapeutique

France

1 November 2019 - 31 October 2020

Region: Global
Subject/journal group: All

The table to the right includes counts of all research outputs for Unit Pulmonary Hypertension: Pathophysiology and Novel Therapies published between 1 November 2019 - 31 October 2020 which are tracked by the Nature Index.

Hover over the donut graph to view the FC output for each subject. Below, the same research outputs are grouped by subject. Click on the subject to drill-down into a list of articles organized by journal, and then by title.

Research collaboration: Unit Pulmonary Hypertension: Pathophysiology and Novel Therapies is a research collaboration whose article contributions are accrued to its participating partner institutions.

Note: Articles may be assigned to more than one subject area.

Count Share
5 0.36

Outputs by subject (Share)

Subject Count Share
Life Sciences 4 0.15
Physical Sciences 1 0
Chemistry 1 0.21

1 November 2019 - 31 October 2020

International vs. domestic collaboration by Share

  • 23.09% Domestic
  • 76.91% International

Note: Hover over the graph to view the percentage of collaboration.

Top 10 domestic collaborators by Share (7 total)

  • Unit Pulmonary Hypertension: Pathophysiology and Novel Therapies, France
  • Domestic institution
  1. Institute of Chemistry of Natural Substances (ICSN), France (0.55)
    0.21
    0.34
  2. Laboratory of Molecular and Structural Archaeology (LAMS), France (0.24)
    0.21
    0.03
  3. Sorbonne University, France (0.23)
    0.21
    0.02
  4. Institute of Cardiometabolism and Nutrition (ICAN), France (0.01)
    0
    0.01
  5. University of Bordeaux, France (0.01)
    0
    0
  6. Cellules Souches Hématopoïétiques et Développement des Hémopathies Myéloïdes, France (0)
    0
    0
  7. Institute Gustave-Roussy (IGR), France (0)
    0
    0

Top 10 international collaborators by Share (192 total)

  • Unit Pulmonary Hypertension: Pathophysiology and Novel Therapies, France
  • Foreign institution
  1. University of Cambridge, United Kingdom (UK) (0.45)
    0
    0.45
  2. IONTOF GmbH, Germany (0.33)
    0.21
    0.13
  3. University of Montreal (UdeM), Canada (0.27)
    0.21
    0.06
  4. NIHR Cambridge Biomedical Research Centre (Cambridge BRC), United Kingdom (UK) (0.17)
    0
    0.17
  5. Cambridge University Hospitals NHS Foundation Trust, United Kingdom (UK) (0.13)
    0
    0.12
  6. Great Ormond Street Hospital for Children NHS Trust, United Kingdom (UK) (0.09)
    0
    0.09
  7. UCL, United Kingdom (UK) (0.09)
    0
    0.09
  8. University of Oxford, United Kingdom (UK) (0.07)
    0
    0.07
  9. Imperial College London (ICL), United Kingdom (UK) (0.07)
    0
    0.07
  10. Guy's and St Thomas' NHS Foundation Trust, United Kingdom (UK) (0.07)
    0
    0.06

Note: Collaboration is determined by the fractional count (Share), which is listed in parentheses.

Unit Pulmonary Hypertension: Pathophysiology and Novel Therapies

Participating institutions

Unit Pulmonary Hypertension: Pathophysiology and Novel Therapies is a research collaboration whose article contributions are accrued to its participating partner institutions below.

Creative Commons License

Numerical information only is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

Return to institution outputs

Except where otherwise noted © 2021 Springer Nature Limited. All Rights Reserved.
partner of AGORA, HINARI, OARE, INASP, ORCID, CrossRef and COUNTER